Replimune Group, Inc. (REPL)

NMS – Real Time Price. Currency in USD

4.40

+0.31 (7.56%)

Market open: May 13, 2026, 9:49 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2024

2023

2022

2021

Total Revenue

Cost of goods sold

-4M

-3M

-2M

-5M

Gross Profit

-4M

-3M

-2M

-5M

Operating expenses (excl. COGS)

-260M

-234M

-178M

-117M

Operating Income

-263M

-237M

-180M

-121M

Non-operating income, total

15M

19M

278K

Pretax income

-249M

-217M

-177M

-121M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-247M

-216M

-174M

-118M

Replimune Group, Inc. (REPL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Replimune Group, Inc. (REPL)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Replimune Group, Inc. (REPL)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Replimune Group, Inc. (REPL)

Income Statement (Annual)

Income Statement (Annual)